GlassScriptPhysician profile
Katherine K Marcel
NPI 1659058907
$3,227.95
in general payments reported to CMS, 2019-2025
20 companies · $1,368 in 2025
The $1,368 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $412 · 2024: $1,448 · 2025: $1,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,227.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $758.08 | 2023-2025 | Fasenra, Tezspire, Wainua |
| Genentech USA, INC. | $553.10 | 2023-2025 | Xolair |
| Genzyme Corporation | $497.05 | 2023-2025 | |
| Glaxosmithkline, LLC. | $365.21 | 2023-2025 | Trelegy Ellipta, Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $197.23 | 2023-2025 | Cuvitru |
| Abbvie INC. | $184.34 | 2024 | |
| Galderma Laboratories, L.P. | $166.25 | 2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $133.13 | 2023-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $129.61 | 2024-2025 | |
| Ars Pharmaceuticals Operations, INC. | $50.93 | 2025 | Neffy |
| Csl Behring | $47.70 | 2023-2025 | Hizentra |
| Grifols USA, LLC | $21.55 | 2024 | Xembify |
| Kaleo, INC. | $21.18 | 2024 | Auvi-Q |
| Greer Laboratories, INC. | $21.02 | 2024 | Palforzia |
| Alk-Abello, INC | $17.45 | 2025 | Grastek, Odactra, Ragwitek |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.62 | 2024 | Tezspire |
| Pharming Healthcare, INC. | $16.35 | 2025 | Ruconest |
| Biocryst US Sales Co., LLC | $16.17 | 2025 | Orladeyo |
| Leo Pharma INC. | $13.08 | 2024 | Adbry |
| Organon LLC | $1.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Marcel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.